Literature DB >> 28836513

Large liver abscess after endoscopic ultrasound-guided fiducial placement.

Galab M Hassan1, Sarto C Paquin1, Anand V Sahai1.   

Abstract

Entities:  

Year:  2017        PMID: 28836513      PMCID: PMC5752768          DOI: 10.4103/eus.eus_17_17

Source DB:  PubMed          Journal:  Endosc Ultrasound        ISSN: 2226-7190            Impact factor:   5.628


× No keyword cloud information.
Dear Editor, Endoscopic ultrasound-guided fiducial placement (EUS-FP), performed to facilitate stereotactic body radiation therapy, is feasible and safe.[12] Antibioprophylaxis is not recommended currently by existing guidelines.[3] We report the first case of a large liver abscess and sepsis after EUS-FP. A 67-year-old female with colon cancer and a single, metastatic, 3 cm left lobar liver lesion was referred for EUS-FP. A single fiducial was back-loaded into the 19-gauge needle (Cook, EchoTip®); the tip was then sealed with sterile bone wax [Figures 1 and 2]. After placement of the first fiducial, the needle was then withdrawn from the scope to back-load the next fiducial. Three fiducials were placed in total using this method. No prophylactic antibiotics were administered.
Figure 1

Under sterile conditions, the fiducial is back-loaded into the needle tip

Figure 2

The needle tip is then sealed with sterile bone wax

Under sterile conditions, the fiducial is back-loaded into the needle tip The needle tip is then sealed with sterile bone wax Six weeks postprocedure, the patient was admitted to the intensive care unit with abdominal pain and septic shock. Computed tomography scan revealed a 10 cm intrahepatic/perigastric abscess in the region where the fiducials had been placed. All resolved with antibiotics and percutaneous drainage. Our institution has performed 43 EUS-FP to date, with only one reported infectious complication (Case #38). We now administer antibioprophylaxis to all patients undergoing EUS-FP. The role of prophylactic antibiotics for EUS-FP was unclear.[3] To the best of our knowledge, only two infectious complications have been reported previously; one cholangitis after EUS-FP of porta hepatis nodes and[4] one cholangitis after EUS-FP for pancreatic head cancer.[3] In both cases, it was uncertain if the infection was related to the procedure or to malignant biliary obstruction. Recent studies with EUS-FP did not systematically administer antibioprophylaxis.[45] In conclusion, postprocedural liver abscess is a possible complication of EUS-FP. Excessive manipulation of the needle, related to the “semi-sterile” back-loading technique, is probably responsible for our reported complication. Therefore, we believe that antibioprophylaxis pre- and post-EUS-FP in these conditions is a reasonable recommendation, and guidelines for prophylaxis should be amended appropriately. EUS-FP infectious risk could likely also be reduced using a needle that allows placement of multiple fiducials, without manual back-loading.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Antibiotic prophylaxis is recommended for endoscopic ultrasound-guided fiducial placements.

Authors:  Shyam Varadarajulu
Journal:  J Clin Gastroenterol       Date:  2011-02       Impact factor: 3.062

2.  The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: a case series.

Authors:  S Varadarajulu; J M Trevino; S Shen; R Jacob
Journal:  Endoscopy       Date:  2010-03-15       Impact factor: 10.093

3.  EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies.

Authors:  Aline Charabaty Pishvaian; Brian Collins; Gregory Gagnon; Sushil Ahlawat; Nadim G Haddad
Journal:  Gastrointest Endosc       Date:  2006-09       Impact factor: 9.427

4.  Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers.

Authors:  Melanie Machiels; Jeanin van Hooft; Peng Jin; Mark I van Berge Henegouwen; Hanneke M van Laarhoven; Tanja Alderliesten; Maarten C Hulshof
Journal:  Gastrointest Endosc       Date:  2015-05-07       Impact factor: 9.427

5.  A pilot study of EUS-guided fiducial insertion for the multidisciplinary management of gastric cancer.

Authors:  Sujievvan Chandran; Rhys Vaughan; Marios Efthymiou; Joseph Sia; Christopher Hamilton
Journal:  Endosc Int Open       Date:  2014-07-18
  5 in total
  1 in total

1.  Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.

Authors:  Shen Pan; Xiao-Qi Wang; Qi-Yong Guo
Journal:  World J Gastroenterol       Date:  2018-05-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.